Correcting the record: Biopharmaceutical companies remain committed to the 340B program and helping patients

TheNew York Times recently ran a story that paints an inaccurate picture of the 340B program, contract pharmacy participation in the program and the biopharmaceutical industry ’s commitment to the program. Today, we’re correcting the record.Fact: Manufacturers are still giving the 340B discounts, as required by law, to “covered entities”– more than 12,700 hospitals and clinics currently participating in the 340B program.Some companies have recently implemented changes to shipment of 340B drugs in response to decades of program failures, which is being mischaracterized by some. These companies are still providing discounts to 340B covered entities, but in some cases not to offsite pharmacies that were never included in the program to begin with when Congress created 340B.
Source: The Catalyst - Category: Pharmaceuticals Tags: 340B Hospitals 340B Spotlight Source Type: news